RESUMO
INTRODUCTION: Active surveillance (AS) is considered a suitable management practice for those patients with low-risk prostate cancer (PCa). At present, however, the role of multiparametric magnetic resonance imaging (mpMRI) in AS protocols has not yet been clearly established. OUTCOMES: To determine the role of mpMRI and its ability to detect significant prostate cancer (SigPCa) in PCa patients enrolled in AS protocols. MATERIALS AND METHODS: There were 229 patients enrolled in an AS protocol between 2011 and 2020 at Reina Sofía University Hospital. MRI interpretation was based on PIRADS v.1 or v.2/2.1 classification. Demographics, clinical, and analytical data were collected and analyzed. Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for mpMRI in different scenarios. We defined SigPCa and reclassification/progression as a Gleason score (GS) ≥ 3 + 4, a clinical stage ≥T2b, or an increase in PCa volume. Kaplan-Meier and log-rank tests were used to estimate progression-free survival time. RESULTS: Median age was 69.02 (±7.73) at diagnosis, with a 0.15 (±0.08) PSA density (PSAD). Eighty-six patients were reclassified after confirmatory biopsy, with a suspicious mpMRI an indication for a clear reclassification and risk-predictor factor in disease progression (p < 0.05). During follow-up, 46 patients were changed from AS to active treatment mainly due to disease progression. Ninety patients underwent ≥2mpMRI during follow-up, with a median follow-up of 29 (15-49) months. Thirty-four patients had a baseline suspicious mpMRI (at diagnostic or confirmatory biopsy): 14 patients with a PIRADS 3 and 20 patients with ≥PIRADS 4. From 14 patients with a PIRADS 3 baseline mpMRI, 29% progressed radiologically, with a 50% progression rate versus 10% (1/10 patients) for those with similar or decreased mpMRI risk. Of the 56 patients with a non-suspicious baseline mpMRI (PIRADS < 2), 14 patients (25%) had an increased degree of radiological suspicion, with a detection rate of SigPCa of 29%. The mpMRI NPV during follow-up was 0.91. CONCLUSION: A suspicious mpMRI increases the reclassification and disease progression risk during follow-up and plays an important role in monitoring biopsies. In addition, a high NPV at mpMRI follow-up can help to decrease the need to monitor biopsies during AS.
Assuntos
Neoplasias da Próstata , Conduta Expectante , Masculino , Humanos , Idoso , Próstata/patologia , Neoplasias da Próstata/patologia , Imageamento por Ressonância Magnética/métodos , Espectroscopia de Ressonância Magnética , Progressão da Doença , Biópsia Guiada por Imagem/métodosRESUMO
OBJECTIVE: To evaluate the need for surgical biopsy in patients diagnosed with radial scars without atypia by percutaneous biopsy. MATERIAL AND METHODS: In this retrospective observational study, we selected patients with a histological diagnosis of radial scar in specimens obtained by percutaneous biopsy during an 8-year period. The statistical analysis was centered on patients with radial scar without atypia (we assessed the radiologic presentation, the results of the percutaneous biopsy, and their correlation with the results of surgical biopsy and follow-up) and we added the patients with atypia and cancer in the elaboration of the diagnostic indices. RESULTS: We identified 96 patients with radial scar on percutaneous biopsy; 54 had no atypia, 18 had atypia, and 24 had cancer. Among patients with radial scar without atypia, there were no statistically significant differences between patients who underwent imaging follow-up and those who underwent surgical biopsy (p>0.05). The rate of underdiagnosis for percutaneous biopsy in patients without atypia was 1.9%. The rates of diagnosis obtained with percutaneous biopsy in relation to follow-up and surgical biopsy in the 96 cases were sensitivity 92.3%, specificity 100%, positive predictive value 100%, negative predictive value 97.2%, and accuracy 97.9%. The area under the ROC curve was 0.96 (p<0.001), and the kappa concordance index was 0.95 (p<0.001) CONCLUSIONS: We consider that it is not necessary to perform surgical biopsies in patients with radial scars without atypia on percutaneous biopsies because the rate of underestimation is very low and the concordance between the diagnosis reached by percutaneous biopsy and the definitive diagnosis is very high.
Assuntos
Doenças Mamárias/patologia , Adulto , Idoso , Biópsia/métodos , Doenças Mamárias/terapia , Feminino , Humanos , Pessoa de Meia-Idade , Estudos Retrospectivos , Adulto JovemRESUMO
Objetivo. Evaluar la necesidad de biopsia quirúrgica en pacientes diagnosticadas por biopsia percutánea de cicatriz radial sin atipia. Material y métodos. Realizamos un estudio observacional retrospectivo y seleccionamos las pacientes con diagnóstico histológico en biopsia percutánea de cicatriz radial durante un periodo de 8 años. El análisis estadístico principal se centró en pacientes con cicatriz radial sin atipia (valoramos la presentación radiológica, los resultados de la biopsia percutánea y su correlación con la biopsia quirúrgica y seguimiento) y añadimos a las pacientes con atipia y cáncer en la elaboración de índices diagnósticos. Resultados. Identificamos 96 pacientes con cicatriz radial en biopsia percutánea. Cincuenta y cuatro no presentaban atipia, 18 asociaban algún tipo de atipia y 24, cáncer. No hubo diferencias estadísticas significativas al comparar las pacientes en seguimiento radiológico con aquellas que se sometieron a biopsia quirúrgica en el grupo sin atipia (p > 0,05). La tasa de infraestimación de la biopsia percutánea en pacientes sin atipia fue del 1,9%. Los índices diagnósticos obtenidos para la biopsia percutánea en relación con el seguimiento y la biopsia quirúrgica en los 96 casos fueron: sensibilidad, 92,3%; especificidad, 100%; valor predictivo positivo, 100%; valor predictivo negativo, 97,2%; y exactitud, 97,9%. El área bajo la curva ROC fue de 0,96 (p < 0,001) y el índice de concordancia kappa de 0,95 (p < 0,001). Conclusión. Consideramos que no es necesario realizar biopsia quirúrgica en pacientes diagnosticadas de cicatriz radial sin atipia en biopsia percutánea, ya que la tasa de infraestimación es muy baja y existe un elevado grado de concordancia entre la biopsia percutánea y el diagnóstico definitivo (AU)
Objective. To evaluate the need for surgical biopsy in patients diagnosed with radial scars without atypia by percutaneous biopsy. Material and methods. In this retrospective observational study, we selected patients with a histological diagnosis of radial scar in specimens obtained by percutaneous biopsy during an 8-year period. The statistical analysis was centered on patients with radial scar without atypia (we assessed the radiologic presentation, the results of the percutaneous biopsy, and their correlation with the results of surgical biopsy and follow-up) and we added the patients with atypia and cancer in the elaboration of the diagnostic indices. Results. We identified 96 patients with radial scar on percutaneous biopsy; 54 had no atypia, 18 had atypia, and 24 had cancer. Among patients with radial scar without atypia, there were no statistically significant differences between patients who underwent imaging follow-up and those who underwent surgical biopsy (p>0.05). The rate of underdiagnosis for percutaneous biopsy in patients without atypia was 1.9%. The rates of diagnosis obtained with percutaneous biopsy in relation to follow-up and surgical biopsy in the 96 cases were sensitivity 92.3%, specificity 100%, positive predictive value 100%, negative predictive value 97.2%, and accuracy 97.9%. The area under the ROC curve was 0.96 (p<0.001), and the kappa concordance index was 0.95 (p<0.001) Conclusions. We consider that it is not necessary to perform surgical biopsies in patients with radial scars without atypia on percutaneous biopsies because the rate of underestimation is very low and the concordance between the diagnosis reached by percutaneous biopsy and the definitive diagnosis is very high (AU)